Skip to main content
Fig. 6 | Genome Medicine

Fig. 6

From: Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations

Fig. 6

Number of patients showing an increase (green) or a decrease (red) in the subclonality of copy number gains genome wide between diagnosis and 12 weeks after treatment for responders (a) and non-responders (b). Significantly more patients showed an increase in the clonality of VEGFA gains and a decrease in the clonality of TMEM100 gains (arrows) across the whole cohort

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us